ArticleCancer treatment and research2023

Clinical Application of Poly(ADP-Ribose) Polymerase (PARP) Inhibitors in Ovarian Cancer.

Melissa M Pham et al.PubMed ↗Publisher ↗

No numbers read from the abstract.